Christopher Weber to Chicago
This is a "connection" page, showing publications Christopher Weber has written about Chicago.
Connection Strength
0.025
-
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860.
Score: 0.025